Artificial Intelligence, and E-Health Literacy in Fibromyalgia
Key facts
- Who runs it
- Gulseren Demir Karakilic
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 212 people enrolled
- Started
- 16 Dec 2024
- Ended
- 30 May 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- Observation only
- Record updated
- 13 June 2025
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Age between 18 and 50 years
- Diagnosis of Fibromyalgia Syndrome according to 2016 American College of Rheumatology criteria (for patient group)
- Adequate cognitive function
- Literacy
- Willingness to participate and provide informed consent
- For control group: Healthy individuals matched by age and sex, with no reported health issues
Who cannot take part
- Cognitive impairment preventing questionnaire completion
- Presence of severe comorbidities or neurological/psychiatric disorders that may affect participation
- Illiteracy
- Refusal or inability to provide informed consent
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This cross-sectional observational study aimed to assess electronic health literacy and artificial intelligence literacy among individuals diagnosed with fibromyalgia syndrome, with particular focus on artificial intelligence literacy. Although general health literacy has been investigated in this patient population, digital and artificial intelligence-related competencies have not been sufficiently studied. The research included 106 individuals diagnosed with fibromyalgia syndrome and 106 age- and sex-matched healthy volunteers, recruited between December 2024 and May 2025. All participants completed a series of standardized questionnaires, including the Revised Fibromyalgia Impact Questionnaire, the Beck Depression Inventory, the Beck Anxiety Inventory, the Electronic Health Literacy Scale, and the Artificial Intelligence Literacy Scale. The study explored demographic, clinical, and psychological factors associated with digital and artificial intelligence literacy levels among both patient and control groups.
The 2 groups in the trial
- the patient group
Patients aged 18 to 50 who attended the Physical Medicine and Rehabilitation outpatient clinic at Bozok University Faculty of Medicine, met the 2016 American College of Rheumatology fibromyalgia diagnostic criteria, demonstrated adequate cognitive function, were literate, and consented to participate were enrolled as the patient group
Treatment: Observation only
- The control group
The control group consisted of healthy volunteers matched to the patient group in terms of age and sex, aged 18-50 years, with intact cognitive function and literacy skills, no reported health issues, and who willingly consented to participate in the study
Treatment: Observation only
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Investigation on Artificial Intelligence Literacy and E-Health Literacy of Patients With Fibromyalgia Syndrome
- Publications
- Record updated
- 13 June 2025